Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets

Ovarian cancer remains the most fatal gynecologic malignancy worldwide due to delayed diagnosis as well as recurrence and drug resistance. Thus, the development of new tumor-related molecules with high sensitivity and specificity to replace or supplement existing tools is urgently needed. Cancer-tes...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Ovarian Res
Autors principals: Xie, Kaipeng, Fu, Chenyang, Wang, Suli, Xu, Hanzi, Liu, Siyu, Shao, Yang, Gong, Zhen, Wu, Xiaoli, Xu, Bo, Han, Jing, Xu, Juan, Xu, Pengfei, Jia, Xuemei, Wu, Jiangping
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6318940/
https://ncbi.nlm.nih.gov/pubmed/30609934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-018-0475-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars